Quantcast

Posts related to ‘CGRB’

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Posted: May 27, 2009 at 1:34 pm

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend.   This is broken down ...
Read Full Story »

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

Posted: May 14, 2009 at 4:56 pm

We are just about to get the first round of abstracts from companies presenting data at this year's American Society of Clinical Oncology meeting for 2009.  At BioHealthInvestor.com we compiled ...
Read Full Story »

Biotech Business Daily (CGRB, DSCO, EPIX, GSK, PSTI, VNDA)

Posted: May 5, 2008 at 1:51 pm

Cougar Biotechnology, Inc. (NASDAQ: CGRB) is up over 5% in afternoon trading on the announcement that they will present a company update and clinical trial update at the Leerink Swann ...
Read Full Story »

Biotech Monday (CRIS, CGRB, EXEL, MNKD, PDLI, SQNM, TCM)

Posted: March 10, 2008 at 2:25 pm

Curis Inc. (NASDAQ: CRIS) shares down 18% after development partner Wyeth terminated their contract that focused on cancer treatment developments. Shares are down $0.29 to $1.14. The 52 week range ...
Read Full Story »